# Avania

Organization · id `cardio:org-avania` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Avania>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Avania
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) (`cardio:ct-nct02661451`)
- Sponsors: US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism (`cardio:ct-nct05127915`)
- Sponsors: Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair (`cardio:ct-nct05421130`)
- Sponsors: Sapphire 3 CTO Study (`cardio:ct-nct06358508`)
- Sponsors: CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation (`cardio:ct-nct06959121`)
- Sponsors: REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease (`cardio:ct-nct07834372`)
- Sponsors: REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care (`cardio:ct-nct07853716`)

## Provenance

Content hash: 75f200ed6b98eaa4c5100dcbca788d8b21bf35856a8eb15ce069f1e5e54941a6
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
